Literature DB >> 27298312

Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.

Sina Burth1, Philipp Kickingereder1, Oliver Eidel1, Diana Tichy1, David Bonekamp1, Lukas Weberling1, Antje Wick1, Sarah Löw1, Anne Hertenstein1, Martha Nowosielski1, Heinz-Peter Schlemmer1, Wolfgang Wick1, Martin Bendszus1, Alexander Radbruch1.   

Abstract

BACKGROUND: The purpose of this study was to determine the relevance of clinical data, apparent diffusion coefficient (ADC), and relative cerebral blood volume (rCBV) from dynamic susceptibility contrast (DSC) perfusion and the volume transfer constant (ktrans) from dynamic contrast-enhanced (DCE) perfusion for predicting overall survival (OS) and progression-free survival (PFS) in newly diagnosed treatment-naïve glioblastoma patients.
METHODS: Preoperative MR scans including standardized contrast-enhanced T1 (cT1), T2 - fluid-attenuated inversion recovery (FLAIR), ADC, DSC, and DCE of 125 patients with subsequent histopathologically confirmed glioblastoma were performed on a 3 Tesla MRI scanner. ADC, DSC, and DCE parameters were analyzed in semiautomatically segmented tumor volumes on contrast-enhanced (CE) cT1 and hyperintense signal changes on T2 FLAIR (ED). Univariate and multivariable Cox regression analyses including age, sex, extent of resection (EOR), and KPS were performed to assess the influence of each parameter on OS and PFS.
RESULTS: Univariate Cox regression analysis demonstrated a significant association of age, KPS, and EOR with PFS and age, KPS, EOR, lower ADC, and higher rCBV with OS. Multivariable analysis showed independent significance of male sex, KPS, EOR, and increased rCBVCE for PFS, and age, sex, KPS, and EOR for OS.
CONCLUSIONS: MRI parameters help to predict OS in a univariate Cox regression analysis, and increased rCBVCE is associated with shorter PFS in the multivariable model. In summary, however, our findings suggest that the relevance of MRI parameters is outperformed by clinical parameters in a multivariable analysis, which limits their prognostic value for survival prediction at the time of initial diagnosis.
© The Author(s) 2016. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  MRI; diffusion; glioblastoma; perfusion; survival

Mesh:

Substances:

Year:  2016        PMID: 27298312      PMCID: PMC5744248          DOI: 10.1093/neuonc/now122

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  52 in total

1.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

2.  Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.

Authors:  Benjamin M Ellingson; Taryar Zaw; Timothy F Cloughesy; Kourosh M Naeini; Shadi Lalezari; Sandy Mong; Albert Lai; Phioanh L Nghiemphu; Whitney B Pope
Journal:  J Magn Reson Imaging       Date:  2012-01-26       Impact factor: 4.813

3.  Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.

Authors:  Whitney B Pope; Hyun J Kim; Jing Huo; Jeffry Alger; Matthew S Brown; David Gjertson; Victor Sai; Jonathan R Young; Leena Tekchandani; Timothy Cloughesy; Paul S Mischel; Albert Lai; Phioanh Nghiemphu; Syed Rahmanuddin; Jonathan Goldin
Journal:  Radiology       Date:  2009-07       Impact factor: 11.105

Review 4.  Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics.

Authors:  Benjamin M Ellingson
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

5.  Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging.

Authors:  Ryuji Murakami; Takeshi Sugahara; Hideo Nakamura; Toshinori Hirai; Mika Kitajima; Yoshiko Hayashida; Yuji Baba; Natsuo Oya; Jun-Ichi Kuratsu; Yasuyuki Yamashita
Journal:  Radiology       Date:  2007-03-13       Impact factor: 11.105

6.  Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma.

Authors:  Daniel A Hamstra; Thomas L Chenevert; Bradford A Moffat; Timothy D Johnson; Charles R Meyer; Suresh K Mukherji; Douglas J Quint; Stephen S Gebarski; Xiaoying Fan; Christina I Tsien; Theodore S Lawrence; Larry Junck; Alnawaz Rehemtulla; Brian D Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-02       Impact factor: 11.205

7.  Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].

Authors:  Michael H Lev; Yelda Ozsunar; John W Henson; Amjad A Rasheed; Glenn D Barest; Griffith R Harsh; Markus M Fitzek; E Antonio Chiocca; James D Rabinov; Andrew N Csavoy; Bruce R Rosen; Fred H Hochberg; Pamela W Schaefer; R Gilberto Gonzalez
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

8.  Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images.

Authors:  Yi Cui; Khin Khin Tha; Shunsuke Terasaka; Shigeru Yamaguchi; Jeff Wang; Kohsuke Kudo; Lei Xing; Hiroki Shirato; Ruijiang Li
Journal:  Radiology       Date:  2015-09-04       Impact factor: 11.105

9.  Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM.

Authors:  Forrest W Crawford; Inas S Khayal; Colleen McGue; Suja Saraswathy; Andrea Pirzkall; Soonmee Cha; Kathleen R Lamborn; Susan M Chang; Mitchel S Berger; Sarah J Nelson
Journal:  J Neurooncol       Date:  2008-11-15       Impact factor: 4.130

Review 10.  FSL.

Authors:  Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

View more
  16 in total

1.  Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.

Authors:  Daniel Paech; Constantin Dreher; Sebastian Regnery; Jan-Eric Meissner; Steffen Goerke; Johannes Windschuh; Johanna Oberhollenzer; Miriam Schultheiss; Katerina Deike-Hofmann; Sebastian Bickelhaupt; Alexander Radbruch; Moritz Zaiss; Andreas Unterberg; Wolfgang Wick; Martin Bendszus; Peter Bachert; Mark E Ladd; Heinz-Peter Schlemmer
Journal:  Eur Radiol       Date:  2019-02-26       Impact factor: 5.315

2.  Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials.

Authors:  Benjamin M Ellingson; Robert J Harris; Davis C Woodworth; Kevin Leu; Okkar Zaw; Warren P Mason; Solmaz Sahebjam; Lauren E Abrey; Dana T Aftab; Gisela M Schwab; Colin Hessel; Albert Lai; Phioanh L Nghiemphu; Whitney B Pope; Patrick Y Wen; Timothy F Cloughesy
Journal:  Neuro Oncol       Date:  2016-08-31       Impact factor: 12.300

3.  Overall survival prediction in glioblastoma patients using structural magnetic resonance imaging (MRI): advanced radiomic features may compensate for lack of advanced MRI modalities.

Authors:  Spyridon Bakas; Gaurav Shukla; Hamed Akbari; Guray Erus; Aristeidis Sotiras; Saima Rathore; Chiharu Sako; Sung Min Ha; Martin Rozycki; Russell T Shinohara; Michel Bilello; Christos Davatzikos
Journal:  J Med Imaging (Bellingham)       Date:  2020-06-09

4.  Semantic imaging features predict disease progression and survival in glioblastoma multiforme patients.

Authors:  Jan C Peeken; Josefine Hesse; Bernhard Haller; Kerstin A Kessel; Fridtjof Nüsslin; Stephanie E Combs
Journal:  Strahlenther Onkol       Date:  2018-02-13       Impact factor: 3.621

5.  Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma.

Authors:  Yi Cui; Shangjie Ren; Khin Khin Tha; Jia Wu; Hiroki Shirato; Ruijiang Li
Journal:  Eur Radiol       Date:  2017-02-06       Impact factor: 5.315

Review 6.  The Role of Advanced Brain Tumor Imaging in the Care of Patients with Central Nervous System Malignancies.

Authors:  K Ina Ly; Elizabeth R Gerstner
Journal:  Curr Treat Options Oncol       Date:  2018-06-21

7.  Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.

Authors:  Agne Ulyte; Vasileios K Katsaros; Evangelia Liouta; Georgios Stranjalis; Christos Boskos; Nickolas Papanikolaou; Jurgita Usinskiene; Sotirios Bisdas
Journal:  Neuroradiology       Date:  2016-10-29       Impact factor: 2.804

Review 8.  Diffusion Weighted/Tensor Imaging, Functional MRI and Perfusion Weighted Imaging in Glioblastoma-Foundations and Future.

Authors:  Gayle R Salama; Linda A Heier; Praneil Patel; Rohan Ramakrishna; Rajiv Magge; Apostolos John Tsiouris
Journal:  Front Neurol       Date:  2018-01-22       Impact factor: 4.003

Review 9.  Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges.

Authors:  Junfeng Zhang; Heng Liu; Haipeng Tong; Sumei Wang; Yizeng Yang; Gang Liu; Weiguo Zhang
Journal:  Contrast Media Mol Imaging       Date:  2017-03-20       Impact factor: 3.161

10.  Multi-parametric and multi-regional histogram analysis of MRI: modality integration reveals imaging phenotypes of glioblastoma.

Authors:  Chao Li; Shuo Wang; Angela Serra; Turid Torheim; Jiun-Lin Yan; Natalie R Boonzaier; Yuan Huang; Tomasz Matys; Mary A McLean; Florian Markowetz; Stephen J Price
Journal:  Eur Radiol       Date:  2019-02-01       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.